Anti-Inflammatory Natural Foods

Prabhala, Harsha; Pai, Christine; Prabhala, Rao

doi:10.1016/b978-0-12-397156-2.00020-x

Cited by 5 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Now countries like Bangladesh and Nepal saw their supplies delayed. 112 In its initial supply, it is reported, the Serum Institute and Bharat Biotech charged LICs higher prices than MICs and HICs, charges that were above cost price. 113 Meanwhile, the Government held up regulatory approval of the Pfizer and Moderna vaccines.…”

Section: Procurementmentioning

confidence: 99%

Patents and other conditions of access to vaccines

Arup

Plahe

2023

World Intellectual Property

View full text Add to dashboard Cite

This paper reviews the experience with access to vaccines during the pandemic. Its inquiry is the extent to which pharmaceutical patents have hindered or enhanced access when compared to other factors or conditions like health spending, manufacturing capacity, and regulatory competence. To conduct the review, the paper queries the regulatory governance perspective when it suggests a decentralised field of legal pluralism will maximise access. It recalls the pre-COVID-19 experience with antiretrovirals to provide pointers to the present situation. It then examines the experience with COVID vaccines under the headings of invention, production, procurement, and distribution. The review finds while patents may hinder access to vaccines, other, essential conditions for access, like independent manufacturing capacity and commitment to procurement, are not established. Regulatory governance must now adopt a much more concerted, coordinated approach, mobilising both patent regulation and other key conditions to further access. The review is an opportunity to gather some of the copious commentary on this issue.

show abstract

Section: Procurementmentioning

confidence: 99%

Patents and other conditions of access to vaccines

Arup

Plahe

2023

World Intellectual Property

View full text Add to dashboard Cite

show abstract

“…Pretreatment with zingerone uplifts the levels of dopamine in the nigrostriatal region by increasing free radical scavenging due to the elevation of superoxide dismutase. Then by implying its protective role in management of Parkinson disease and its associated symptoms [ 59 , 60 ]. The plant, in combination with natural vitamin E or tocopherols, has been also studied for its curative effects in the management of bipolar disorder, attention deficit hyperactivity disorder and other neurodevelopmental diseases.…”

Section: Natural Products and Their Protective Role In Management Of ...mentioning

confidence: 99%

Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders

et al. 2022

View full text Add to dashboard Cite

The longstanding progressive neurodegenerative conditions of the central nervous system arise mainly due to deterioration, degradation and eventual neuronal cell loss. As an individual ages, the irreversible neurodegenerative disorders associated with aging also begin to develop, and these have become exceedingly prominent and pose a significant burden mentally, socially and economically on both the individual and their family. These disorders express several symptoms, such as tremors, dystonia, loss of cognitive functions, impairment of motor activity leading to immobility, loss of memory and many more which worsen with time. The treatment employed in management of these debilitating neurodegenerative disorders, such as Parkinson’s disease (which mainly involves the loss of dopaminergic neurons in the nigrostriatal region), Alzheimer’s disease (which arises due to accumulation of Tau proteins causing diffusive atrophy in the brain), Huntington’s disease (which involves damage of striatal and spinal neurons, etc.), have several adverse effects, leading to exploration of several lead targets and molecules existing in herbal drugs. The current review highlights the mechanistic role of natural products in the treatment of several neurodegenerative and cerebrovascular diseases such as Parkinson’s disease, Alzheimer’s disease, ischemic stroke and depression.

show abstract

Recent Advances in Bioactivities of Common Food Biocompounactives

Guaâdaoui

2017

Fruit and Vegetable Phytochemicals

View full text Add to dashboard Cite

Anti-Inflammatory Natural Foods

Cited by 5 publications

References 9 publications

Patents and other conditions of access to vaccines

Patents and other conditions of access to vaccines

Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders

Recent Advances in Bioactivities of Common Food Biocompounactives

Contact Info

Product

Resources

About